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Abstract 
According to the World Health Organization (WHO), Leishmaniasis’ endemic areas have spread 
and the prevalence of the disease has increased, as well as the number of reported cases. 
Europe is one of the most affected continents concerning the risk of re-emergency of this 
zoonosis. 
Feline Leishmaniasis (FeL) was for the first time described in Algeria, 1912. The significance of 
the cat as a reservoir of Leishmania and not simply an alternative host seems to be gaining 
ground, mainly because: i) cats can present increased seropositivity between serology analysis; 
ii) cats can be infected during some months and thus are available for sand flies; iii) cats 
transmit the Leishmania agent in a competent form.  
Furthermore, cats have behavioral characteristics that contribute to the infection by Leishmania 
infantum, and as such, FeL has been reported worldwide. When clinical signs of FeL are 
present, they are usually cutaneous, with unspecific dermatological changes, that frequently 
occur in other feline diseases and if not diagnosed can contribute to an underestimation of the 
actual occurrence of the disease in cats. The low seroprevalence titers along with the commonly 
asymptomatic infection in cats can further contribute to the underestimation of FeL occurrence. 
This work aims to bring up to date the current status of FeL infection worldwide. It comprises a 
review of the most recent case reports and surveillance studies. Although currently limited, the 
most relevant and recent information on the parasite, vector, epidemiology, pathology, and 
immune response is presented, as well as available diagnostic and treatment strategies. The 
knowledge of the epidemiological and immunopathological features of FeL, in some aspects so 
different from the Canine Leishmaniasis (CanL), can be used as a tool in an attempt to prevent 
infection and decrease the hazard that FeL can embody for both humans and cats. 
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1. Introduction  
The natural transmission of Leishmaniasis is classified as zoonotic, involving vertebrate hosts 
who function as reservoirs, being humans’ accidental hosts; or anthroponotic, in which the 
epidemiologic cycle is established between the vectors and the human beings, with the later 
acting as reservoirs (Quinnell and Courtenay, 2009). Several Leishmania infantum hosts have 
already been identified, namely bats (Savani et al., 2010), iberian hares (Lepus granatensis), 
wolfs (Canis lupus), red foxes (Vulpes vulpes) (Criado-Fornelio, 2000), egyptian mongooses 
(Herpestes ichneumon), genets (Geneta geneta), iberian lynx (Lynx pardinus),  pine martens 
(Martes martes) (Ruiz-Fons et al., 2013), crab-eating foxes (Cerdocyon thous) (Catenaci et al., 
2010), horses (Koehler et al., 2002; Rolão et al., 2005; Gramiccia, 2011), rats (Akhavan et al., 
2010), and lions (Panthera leo) (Dahroug et al., 2011).  Pigs that apparently resist to the 
infection, produce protective antibodies against the different antigens of Leishmania infantum, 
and thus are able to keep the parasitized phlebotomines in the surrounding geographic area 
(Moraes-Silva et al., 2006). 
Leishmaniasis in domestic cats (Felis catus domesticus) was described for the first time in 1912, 
in Algeria, in a cat that lived with a dog and a child, both infected with Leishmaniasis (Longoni et 
al., 2012). Since then, Feline Leishmaniasis (FeL) has been reported globally, but more 
frequently in countries bordering the Mediterranean sea (Solano-Gallego, et al., 2007), namely 
Spain (Navarro et al., 2010; Millán et al., 2011), France (Bourdoiseau, 2011; Pocholle et al., 
2012), Italy (Poli et al., 2002; Spada, et al., 2013) and Greece (Diakou et al., 2009). FeL was  
also reported in other neighboring countries like Portugal (Maia et al., 2008, 2010; Marcos et al., 
2009; Cardoso, et al, 2010; Vilhena et al., 2013), Israel (Nasereddin et al.,2008), Switzerland 
(Rüfenacht et al., 2005), and Iran (Hatam et al., 2010). In the American continent, FeL was 
reported particularly in Central America (Trainor et al., 2010), Brazil (Vides et al., 2011; 
Sobrinho et al., 2012), and Paraguay (Velázquez et al., 2011). 
According to the World Health Organization (WHO), Leishmaniasis’ endemic areas have spread 
and the prevalence of the disease has increased, as well as the number of reported cases 
(Ready, 2010). Europe is one of the most affected continents concerning the risk of re-
emergency of the disease by several reasons: appearance of exotic Leishmania species 
(motivated by the increased mobility between some countries); increased population density, 
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associated with factors that cause immune-depressed populations (Brachelente et al., 2005); 
resistance of parasites and vectors to the drugs and insecticides used; and, finally, 
dissemination of Leishmaniasis to neighboring countries, that present tempered climates, as a 
result of environmental and social-economic changes, as well as human and animal migration 
movement (Solano-Gallego et al., 2007; Campino and Maia, 2010). 
In Portugal, current regulation (Decreto-lei nº 314/2003, December 17th) establishes the 
National Program for the Control and Epidemiological Surveillance of Animal Rabies and other 
Zoonosis (PNLVERAZ), defining Leishmaniasis as a “zoonosis of risk”. Indeed, and similarly to 
other countries of Southern Europe, Portugal has registered increasing cases of Human 
Leishmaniasis (HuL). Between 2000 and 2009, the Unit of Leishmaniasis of the Institute of 
Hygiene and Tropical Medicine, in Lisbon, identified 173 new human cases of Visceral 
Leishmaniasis (VL). Among these 173 cases, 107 where related to immunosuppressed people, 
with concomitant Human Immunodeficiency Virus (HIV) infection. The remaining were adult and 
children. Previously, Leishmaniasis was considered predominantly a child disease (Campino 
and Maia, 2010).Concerning the Public Health impact of the Canine Leishmaniasis (CaL), FeL 
must also be considered in the veterinary practice, and its control should be implemented, 
appealing to pharmacological strategies (Maroli et al., 2007). 
The clinical diagnosis of FeL is hampered by the non-pathognomonic clinical signs in cats and 
the fact that some are asymptomatic. Furthermore, it is noteworthy that cats have been 
considered as uncommon hosts for Leishmania (Poli et al., 2002; Mártin-Sánchez et al., 2007; 
Bresciani et al., 2010; Longoni et al., 2012). 
This work aims to bring up to date the current status of FeL infection worldwide. It comprises a 
review of the most recent case reports and surveillance studies. Although currently limited, the 
most relevant and recent information on the parasite, vector, epidemiology, pathology, and 
immune response is presented, as well as available diagnostic and treatment strategies. The 
knowledge of the epidemiological and immunopathological features of FeL, in some aspects so 
different from the CanL, can be used as a tool in an attempt to prevent infection and decrease 
the hazard that FeL can embody for both humans and cats. 
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2. The Parasite 
Leishmaniasis is a parasitic disease caused by an obligate intracellular protozoan, of the genus 
Leishmania (Kinetoplastida, Trypanosomatidae) (Solano-Gallego and Baneth, 2006).  
Species from genus Leishmania identified as infective for felines are subdivided in two 
subgenus: Leishmania (that includes the species characteristic from Old World, namely L. 
major, L. infantum, L. donovani, and that found in the New World: L. mexicana, L. amazonensis, 
L. venezuelensis) and Viannia (only occurring in Central and South America, e.g. specie L. 
(Viannia) braziliensis) (Killing-Kendrick, 2002; Martín-Sánchez et al., 2006; Solano-Gallego and 
Baneth, 2006;Trainor et al., 2010).  
Leishmania infantum is also known as L. chagasi (Tomás and Romão et al., 2008; da Silva et 
al., 2008) despite the suggestion that L. infantum and L. chagasi are distinct species (Gramiccia 
and Longoni, 2005). Some lineages of Leishmania infantum are identified by DNA sequencing, 
monoclonal antibody reactivity to membrane antigens and also by the typification of isoenzymes 
throw electrophoresis. The last one allows the  classification of lineages of L. infantum in 
zymodemes (MON), which result from different migration patterns of the isoenzymes according 
to the enzymatic systems present (Solano-Gallego and Baneth, 2006; Pennisi and Solano-
Gallego et al., 2013). Several zymodemes have already been described in Leishmania 
infantum, being MON-1 the most frequently reported and assumed as the responsible for 
zoonotic Leishmaniasis, affecting humans, canines, felines and other hosts. In fact, the majority 
of the clinical cases of FeL caused by Leishmania infantum reported in Europe belongs to 
zymodeme MON-1 (Ozon et al., 1998; Pratlong et al., 2004; Grevot et al., 2005; Cardoso et al., 
2010; Maia et al., 2010; Gramiccia, 2011). 
Besides MON-1, Pratlong et al. (2004) identified further six zymodemes (MON-11, MON-24, 
MON-29, MON-33, MON-34, and MON-108) which differ from MON-1 in only one of three 
enzymatic systems. Zymodemes seem to be related with the genetic expression of 
Leishmaniasis. The existence of polymorphism in some enzymatic systems of Leishmania 
infantum is suggested as relevant in the clinical expression of the illness. Such polymorphisms 
can result from genetic exchanges between the parasites or, according to other hypothesis, 
from translational or posttranscriptional modifications of certain enzymes codified by a 
multigenic family. 
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During its lifecycle, Leishmania presents two main forms: promastigote (fusiform and flagellated 
living in the phlebotomine vector) and amastigote (ovoid with intracellular flagella infecting the 
host macrophages). Protozoan from genus Leishmania replicates by binary division, initiated in 
the kinetoplast, followed by flagella and nuclei, respectively.  Some authors describe the rare 
existence of sexual reproduction phenomena (Tomás and Romão, 2008). 
Female sand flies acquire Leishmania parasites when they feed on an infected vertebrate host 
in search of a blood meal. During feeding, sand fly mouth parts cause injury in the host’s skin 
and Leishmania amastigotes are transferred from the infected vertebrate being ingested by the 
vector. In the gut of the vector, Leishmania amastigotes develop into Leishmania promastigotes 
which multiply quickly by binary division. 
A process apparently mediated by lipophosphoglycans fix the promastigotes to the internal 
surface of the abdominal midgut (Killick-Kendrick, 2002). 
The structure of the membrane glycoconjugate of the promastigotes varies according to the 
Leishmania species, considering that union of the parasite to intestinal cellular membrane 
requires molecular specificity, depending on the arthropod species. According to Killick-
Kendrick (2002) lecithin, which exist in increased values in the female intestines, could act for 
molecular adhesion factor. 
Initially, the parasite is confined inside of a peritrophic membrane produced by the arthropod 
intestinal cells, differentiating in procyclic promastigotes. Production of chitinolytic enzymes 
causes their release into the intestinal lumen. These procyclic promastigotes develop 
successively into metacyclic promastigotes losing the ability to replicate. An intermediate form, 
called haptomonad promastigotes fix to stomodaeal valve through hemidesmosomes, allowing 
that metacyclic promastigotes reach the oral cavity. Salivary glands are not colonized, and 
promastigotes are inoculated through regurgitation, when the female takes a meal. Leishmania 
amastigotes occur inside the vertebrate host’s macrophages and dendritic cells. These forms 
can infect neutrophils in a first instance, but their replication occurs inside macrophages (Tomás 
and Romão, 2008).  
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3. Vectors Bio-ecology 
Phlebotomine sand flies measure on average 3 mm long and move in an area with about 1 km 
from the breeding site. Their activity occurs mainly at night and twilight avoiding windy 
conditions. In Mediterranean region the activity occurs between May and October when the 
temperature ranges from 15 to 28 ºC. In tropical climate countries, the sand flies have activity 
during the entire year (Solano-Gallego and Baneth, 2006; Solano-Gallego and Cardoso, 2013).   
The vectors of Leishmania spp. belong to the genus Phlebotomus (Diptera, Psychodidae) in Old 
World, and Lutzomya, in the New World (Afonso and Alves-Pires, 2008; Simões-Mattos et al., 
2004). The main vectors of this parasitosis in Portugal are Phlebotomus perniciosus Newstead, 
1911, and P. ariasi Tonnoir, 1921 (Maia et al., 2009). However, transmission of Leishmania in 
the Old World is probably not exclusive by arthropods from the genus Phlebotomus, given that 
recently, in Portugal, Campino et al. (2013) reported the occurrence of Leishmania major in 
sand flies from Sergentomya minuta specie, in Algarve region. This finding suggests that L. 
major circulating in Portugal represents a risk of introduction of new species in Portugal from 
North Africa and India given that Human CL (Cutaneous Leishmaniasis) caused by L. major 
occurs in the Eastern Mediterranean region, from Morocco to Afghanistan. 
Human CL cases have been described in Portugal since 1940s. The cases are mostly located 
in the watershed of the rivers Douro, Tejo and Sado (Campino and Maia, 2010), and thus this 
zoonosis occurs in moist areas with 45-80 % relative humidity, despite the life cycle of the 
vector does not include the water (Solano-Gallego and Cardoso, 2013). 
Some phlebotomines species show feeding preferences. Maroli et al. (2007) considered that the 
feeding preference of the female of Phlebotomus sergenti was cats and birds, while the feeding 
preference of the female of Phlebotomus papatasi was cats and dogs. 
The occurrence of L. infantum autochthones cases in the North Europe, in regions of high 
latitude, where the occurrence of phlebotomines was not described, support the theory that 
other vectors might be involved in the transmission (Quinnell and Courtenay, 2009). Indeed, in 
laboratory conditions it was demonstrated that Rhipicephalus sanguineus, the brown dog tick, 
was able to transmit L. infantum to rodents. Moreover, a transestadial transmission of L. 
infantum was demonstrated in R. sanguineus, more specifically in a nymph that became 
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infected after feeding in an infected dog and that remained infected in the adult stage after 
feeding in a non-infected dog (Morais et al. 2013). 
Similar reports were described in fleas and lices. Authors detected L. infantum in 58.62 % of 
Ctenocephalides felis (Morais et al., 2013). Nevertheless, the role of these ectoparasites in the 
transmission should not be neglected, and eventually they should be proposed as sentinels, on 
the spreading of L. infantum in risk areas, constituting, thus, a surveillance method of this 
parasite. 
However, the role of these ectoparasites as vectors is controversial, with some authors arguing 
that the presence of the protozoan genetic material does not imply ability to transmit Leishmania 
to the vertebrate hosts (Killick-Kendrick, 2002; Solano-Gallego and Baneth, 2006).  
 
4. Epidemiology of Feline Leishmaniasis  
In European countries, Leishmania infantum is the responsible agent for the zoonosis (Tomás 
et al., 2008; da Silva et al., 2008). However, anthroponotic CL caused by Leishmania tropica, 
occurs sporadically in Greece. More recently, another species, L. donovani, considered 
anthroponotic, has been reported in Cyprus, causing Leishmaniasis in both cutaneous and 
visceral forms (Gradoni, 2013). Previously, in an epidemiological study carried in the Nepal, 
Deoxyribonucleic Acid (DNA) from Leishmania donovani was found in the blood of goat, bovine 
and buffalos (Bhattarai et al., 2010). 
Recent cases and studies involving the occurrence of Leishmania in cats suggest that these 
animals act as reservoirs (Solano-Gallego et al., 2007; da Silva et al., 2008; Gramiccia, 2011). 
The discussion regarding the classification of cats as accidental or alternative hosts, primary or 
secondary reservoirs continues (Solano-Gallego et al., 2007; da Silva et al., 2008; Navarro et 
al., 2010; Gramiccia, 2011). 
According with the WHO classification, three types of hosts exist: primary, secondary and 
accidental. The vertebrate mammals of the orders Primate (e.g. humans) and Carnivore (e.g. 
dogs, foxes, wolves) are considered primary hosts (Longoni et al., 2012). 
The classification of a host as primary, secondary (Sín. minor) or accidental is based in the 
capacity of Leishmania species to persist, indefinitely or temporarily in a population that is 
reservoir of the disease, characterized by a basic reproduction number (R0). Quinnell and 
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Courtenay (2009) claim that the R0 value must be higher than 1 to confirm the animal as a main 
host. The main host is responsible for transmitting indefinitely the agent in the nature and is 
often asymptomatic. Two main hosts are able to exist and operate in the same area, linking the 
domestic and sylvatic cycles. 
According to the same authors, to verify the condition of secondary hosts, the R0 is increased. 
Although a secondary host can transmit the infection, it does not guarantee the transmission 
without the presence of the primary host(s). Accidental hosts can be also infected, but usually 
they do not transmit the parasite, and thus do not influence the R0 value. 
Available data from epidemiological surveys (Table 1) and case reports (Table 2) suggest that 
the cat can act as an alternative host of L. infantum, and not as an accidental host, for several 
reasons, as follows (Gramiccia and Gradoni, 2005; Grevot et al., 2005; Maroli et al., 2007; Maia 
et al., 2010): 1) cats can be infected and do not develop illness; even if they present clinical 
signs, a chronic presentation will ensue; 2) in the peripheral blood of cats, the protozoan is in 
the infective form for the vector, i.e. they are infecting for the vector; 3) cats cohabit with human 
beings, namely in endemic areas of CaL; 4) sick cats infected with Leishmania do not recover 
without anti-Leishmanial therapy. 
Cats have behavioral characteristics that can contribute to exposure: they are nocturnal 
predators, operating in a 1.5 km radius from its residence, being able to use forests as a hunting 
territory and, therefore, being ideal elements to link the sylvatic and domestic cycles, favoring 
the dissemination of the parasite (da Silva et al., 2008). Thus some authors claim that cats can 
be considered as disease amplifiers (Maia et al., 2009), which renders further importance to the 
assessment of the epidemiological role of the cat through further studies.  
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Table 1. Compilation of worldwide epidemiologic surveys of Feline Leishmaniasis due to Leishmania infantum. 
Country (region) Seroprevalence (total number of samples) Diagnostic Assay Confirmatory Assay: Results Reference 
ITALY 
 (Milan) 25.3% (233) IFI qPCR: 0% Spada et al. (2013) 
BRAZIL 
(Araçatuba) 4.64% (302) IFI 
ELISA: 12.91% 
Direct Parasitological Exam: 9.93% Sobrinho et al. (2012) 
MEXICO 
(Yucatan Peninsula) 22.1% (95) ELISA (Fe-SOD) - Longoni et al. (2012) 
PARAGUAY 
(Asuncion) 0.94% (317) IFI - Velásquez et al. (2012) 
BRAZIL 
(Araçatuba) 
25.4% (55) 
10.9% (55) 
ELISA 
IFI - Vides et al. (2011) 
IRAN 25%(40) IFI  DAT - Hatam et al. (2010) 
PORTUGAL 
(Lisbon)  1.3%(142) IFI PCR: 20.3 % (28/138) Maia et al. (2010) 
PORTUGAL 
(North region) 2.8% (316)  
DAT 
ELISA - Cardoso et al. (2010) 
GREECE 
(North region) 3.87% (284) ELISA - Diakou et al. (2009) 
ISRAEL 
(Jerusalem) 6.7%(104) ELISA - Nasereddin et al. (2008) 
PORTUGAL  
(Lisbon) 20% (20) IFI PCR: 30.4 % (7/23) Maia et al. (2008) 
SPAIN  
(South region) 
60% (183) with title ≥ 10 
28.3% (183) with title ≥ 40 IFI 
PCR- ELISA: 25.7 % 
Direct Parasitological Exam: 3 of 7 
tested positive 
Martín-Sánchez  et al. (2007) 
ITALY 16.3% (203) IFI - Vita et al. (2005) 
ITALY 0.9% (110) IFI - Poli et al. (2002) 
FRANCE 12.4% (97) Wb - Ozon et al. (1999)  
 
(DAT, Direct Agglutination Test; ELISA, Enzyme-Linked Immunosorbent Assay; Fe-SOD, Iron SuperOxide Dismutase;  
IFI, Indirect Immunofluorescence; PCR, conventional Polymerase Chain Reaction; qPCR, Real-time Polymerase Chain Reaction; Wb, Western blot) 
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Table 2. Compilation of worldwide case reports of Feline Leishmaniasis due to Leishmania infantum. 
 
Country (region) 
 
Cat Identification Diagnostic Assay Reference 
FRANCE  
(South,  St. André 
Roche) 
14-years-old male cat 
Histopathology 
Western blot 
qPCR 
Blood culture 
Pocholle et al. (2012) 
PORTUGAL 
(Porto) 4-years-old female cat 
Bone marrow cytology 
Buffy coat cytology 
PCR 
Indirect hemaglutination test 
Marcos et al. (2009) 
FRANCE 
 (South, Biot) 6-year-sold female cat 
Histopathology 
Bone marrow cytology 
PCR 
Ozon et al. (2005) 
FRANCE  
(South, Grasse)  13-years-old neutered male cat 
IFI 
ELISA 
Histopathology 
Western blot 
Blood culture 
Grevot et al. (2005) 
SPAIN 
(Barcelona) 8-years-old female cat 
ELISA 
Ocular histopathology 
Bone marrow cytology 
PCR 
Leiva et al. (2005) 
BRAZIL 
(São Paulo) 2-years-old male cat 
IFI  
PCR Savani et al. (2004) 
ITALY 
14-years-old female cat 
 
IFI, lesions cytology 
Pennisi et al. (2002) 
6-years-old male cat 
 
Lymph node cytology, PCR, IFI 
10-years-old female cat 
 
Lymph node cytology, PCR, IFI 
Adult male cat Lymph node cytology, PCR, IFI 
ITALY  
(Imperia) 6-years-old female cat 
IFI 
Histopathology 
Lesion and lymph node cytology 
PCR 
Electron microscopy 
Poli et al. (2002) 
SPAIN 
3-years-old female cat IFI Popliteal lymph node cytology Hervás et al. (1999) 
5-years-old female cat Histopathology Electron microscopy 
 
(PCR, Polymerase Chain Reaction; ELISA, Enzyme-Linked Immunosorbent Assay; IFI, Indirect Immunofluorescence;   
qPCR, Real-time Polymerase Chain Reaction) 
121212 
In a study carried in the North of Portugal (Alto-Douro-e-Trás-os-Montes region), considered 
endemic for CaL, Cardoso et al. (2010)  analyzed serum of 242 felines, correlating factors as 
age, race, origin, gender, origin (agricultural or urban) and habitat (indoor or outdoor). Although 
they reported a low seroprevalence (2.8 %) when compared with similar studies, it was possible 
to observe  that positive animals were adult or aged animals (between 24 and 204 months), 
males revealed significantly higher frequency of positivity (4.7 %) compared to the females (0.7 
%). In addition, felines from rural environment were also more frequently infected (10.5 %). 
According to authors of this study, these findings probably result from a cumulative exposition to 
the infection, due to behavioral attitudes that cats present in their territorial and sexual exploring 
attitudes. The remaining studied factors (cats habitat regime - indoor or outdoor, clinical 
manifestation and breed) did not show any positive statistical correlation with the infection. 
Nasereddin et al. (2008) studied the relation between FeL infection and altitude, detecting 86 % 
(6/7) of seropositivity in the tested cats, resident above of the 762 meters. 
In a study carried out in Portugal, using PCR (Polymerase Chain Reaction) assay, (Maia et al., 
2010), 18.5 % (17/92) of the cats and 31.4 % (43/137) of the dogs were positive during the no-
transmission period for the sand fly, i.e. between October and May. During the transmission 
season, the number of positivity increased in both populations of cats (22.0 %; 11/50) and dogs 
(60.0 %; 9/15).However, and in accordance with the authors of the study, additional studies 
would be necessary to determine if the infection in these animals maintains, through reliable 
evaluation techniques, and considering more than one transmission season.  
It is noteworthy that recent studies on CaL show the possibility of occurrence of other horizontal 
transmission form besides sand flies, namely through blood transfusion, as well as other vertical 
transmission form,   through the placenta with occurrence of placentitis in VL (Gibson-Corley et 
al., 2008; Boggiatto et al., 2011). The infection in dogs can still be acquired through transplant 
of contaminated organs and needles (Morais et al., 2013).  Venereal transmission in dogs, until 
then considered impossible, was scientifically proven in a study of da Silva et al. (2008), by the 
presence of Leishmania chagasi in infected dog’s semen. Leishmania amastigotes infect the 
female, due to mechanical trauma of the genitalia of the female, inherent to proper copula.  
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5. Pathogenesis and Lesions  
According to the epidemiological surveys and case reports consulted, felines are usually 
asymptomatic (Solano-Gallego et al., 2007; Nasereddin et al., 2008; Maya et al., 2010), what 
raises questions about their classification as accidental or alternative hosts, as discussed 
above. As a revealing example, in the study of Costa et al. (2010) entailing a population of 200 
cats, only 2 animals revealed clinical signs, in the form of crusty lesions of the dorsal cervical 
region along with hepatosplenomegaly. 
Overall, clinical signs of the disease are comprised in three main clinical forms. VL, caused by 
L. donovani and L. infantum is considered less common in cats. This clinical form is associated 
with high mortality and features a systemic involvement of the organism. CL and Muco-
Cutaneous Leishmaniais (MCL) caused by L. major, dermotropic L. infantum, and L. brasiliensis 
are associated with significant morbidity, compromising the tegumentar and mucosal systems 
(Hervás et al., 1999; Navarro et al., 2010; Gramiccia, 2011). 
The first reported cases of FeL were characterized by cutaneous manifestation, without visceral 
involvement (Bonfante-Garrido et al., 1996; Ozon et al., 1998; Hervás et al., 1999; Pennisi, 
2002; Bourdoiseau, 2011), with dry local lesions, as papules and nodules, and exudative 
lesions, as crusts and ulcers (Maroli et al., 2007; Gramiccia, 2011). The importance of the 
screening of cats presenting dermatitis, nodular or ulcerative was further demonstrated by 
Navarro et al. (2010). In this study, 15 cats infected with leishmaniasis presented the cutaneous 
expression of the illness, namely skin lesions in mucocutaneous junction (nose, lips and ears) 
as well as ocular lesions.  Coelho et al. (2011) also described granulomatous perifoliculitis, 
dermatitis lichenoid and pododermatitis in cats with Leishmaniasis. VL is considered little 
common in the cats. Similarly, in the South of France, Pocholle et al. (2012), described a clinical 
case of a 14-years-old Feline Immunodeficiency Virus (FIV) positive cat, with a 3-year history of 
recurrent pododermatitis, not responsive the antibiotics and characterized by exudative and 
erythematosus lesions. Besides a 20 % weight loss, the cat presented three cutaneous injuries 
(at the base of the ear, head, and interscapular region), all with aspect of ulcerated or 
hemorrhagic papules, but circumscribed. A fourth lesion in the auricular pavilion was identified, 
compatible with carcinoma of the squamous cells. 
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Clinical manifestations entailing lymphadenomegaly were also reported. Maroli et al. (2007) 
described a cat with FeL, presenting as the only clinical sign lymphadenomegaly of the 
mandibular lymph node and mild periodentitis. In the case reported by Denuziére (1976), 
beyond lymphadenomegaly, the cat presented fever. In Spain an infected female cat presented 
lymphadenomegaly in addition to dermatological lesions as scaling and alopecia of head and 
abdomen, as well as ulcers in the bone prominences. History of abortion was also referred 
(Hervás et al., 1999). Located lymphadenopathy of the popliteal lymph node, along with 
onicogrifosis, cachexia with muscular atrophy, and weakness were described in a cat with a left 
pinna wound (da Silva et al., 2010).  
Ocular Leishmaniasis also was reported, with ocular lesions such as corneal exudative ulcers, 
panuveitis and panoftalmitis (Leiva et al., 2005; Navarro et al., 2010).  
Although more seldom, cats with VL, but without cutaneous signals have also been referred, 
presenting at clinical examination fever, jaundice, vomits, lymphadenomegaly, lesions of the 
oral mucosa with gingivitis, anemia, leukopenia (Leiva et al., 2005; Maroli et al., 2007; Marcos 
et al., 2009).  
Renal failure associated with FeL seems less evident than in dog, among which it is a well-
recognized syndrome and a cause of death. Navarro et al. (2010) identified a feline that died 
with renal insufficiency, and two that developed the same clinical picture, few months after 
being diagnosed with Leishmaniasis. 
Some investigators further propose a synergism between squamous cells carcinoma and FeL, 
claiming that while the carcinoma could take advantage of the proliferation of the protozoan, the 
parasite could initiate the development of the neoplasia. The primary cause of dermal ulcers 
can be the protozoan, the neoplasia, or even both. Lesions compatible with squamous cells 
carcinoma were described in the left temporal region of a 13-years-old cat (Grevot et al., 2005) 
and  in the auricular pavilion of a 14-years-old cat (Pocholle et al., 2012), both FIV-positive. 
It is noticeable that FIV and/or Feline Leukemia Virus (FeLV) infections were referred, during 
some time, as predisposing factors to the infection by Leishmania infantum explained by the 
ensuing immunosuppression (Pennisi et al., 2004; Simões-Mattos et al., 2005; Costa et al., 
2010).  
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Supporting studies include the one of Pennisi et al. (2002) that found 70 % of cats positive to 
Leishmaniasis and FIV. Similarly, Sobrinho et al. (2012) found a positive association between 
FeL and FIV infection in 70.59 % of the tested cats. 
In a study lead by Sherry et al. (2011), in the Ibiza Island, infection by Leishmania and FeLV 
also featured a statistical correlation. 
However, the results of some studies contradict this positive correlation between FIV and/or 
FeLV and FeL infection (Ozon et al., 1998; Savani et al., 2004; Vita et al., 2005; Maroli et al., 
2007; Solano-Gallego et al., 2007; Marcos et al., 2009; Maia et al., 2010; da Silva et al., 2010; 
Bourdoiseau, 2011; Coelho et al., 2011). In Brazil, Savani et al. (2004) reported the first FeL 
autochthonous case, in a 2-years-old cat that was FIV- and FeLV-negative, but positive to 
Feline Infectious Peritonitis (FIP). The cat presented a nodular lesion in its nose and visceral 
commitment. 
Regarding Toxoplasma gondii, of which cats are considered reservoirs, the majority of the 
studies did not observed a positive correlation between both infections (Nasereddin et al., 2008; 
Cardoso et al., 2010; Coelho et al., 2011; Sherry et al., 2011).  
Finally, the relation of FeL with infections by Trypanosoma cruzi was studied by Longoni et al., 
(2012) in a population of 95 stray cats of the Yucatan Peninsula, in Mexico. The seropositivity 
was generally considered low, but they found co-infection of T. cruzi with three Leishmania 
species, specifically L. mexicana (10.5 %), L. brasiliensis (11.75 %), and L. infantum (22.1 %).  
 
6. Immunological Features of Leishmania 
It is well ascertained that in the canine model, the parasite depresses the innate immune 
defense of the host and survives in the interior of phagolysosomes, in the interior of the infected 
macrophages, producing lipophosphoglycans (Solano-Gallego and Baneth, 2006).Thus, in CaL 
an effective immune response requires Cell-Mediated Immunity (CMI), being macrophages the 
responsible ones in the control of the infection by Leishmania. 
As depicted in Figure 1, the activated Type-1 T-helper cell (Th1) induce the anti-Leishmania 
activity of macrophages through secretion of cytokines such as interferon gamma (IFN-ᵞ), 
interleukin-2 (IL-2) and alpha tumoral necrosis factor (TNF-α). The nitric oxide (NO) produced 
by the macrophages is the main mediator molecule of the intracellular destruction of the 
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Figure1. Suggested immune response of felines in Leishmania infection, according with 
immune mechanism in CaL (modified from Barbiéri, 2006; Baneth et al., 2008; Saz et al., 2013) 
(IFN-Ɣ, Gamma Interferon; Ig, Immunoglobulin; IL, Interleukin; MCH II, Major Histocompatibility Complex; NO, Nitric 
Oxide; P, Plasma Cell ; Tc, Citotoxic Cell;TCD4+, T-helper Cell; Th1, Type-1 T-helper cell; Th2, Type-2 T-helper Cell; ; 
TGF-β, Transformation Growth Factor Beta; TNFα, Alpha Tumor Necrosis Factor; Treg, Regulatory T-cell).   
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predominantly by Th1 cells; clinical manifestation and clinical regression is common among 
immune responses mediated predominantly by Th2 cells).  
According to in vivo and in vitro studies, CD4+ Th cells are the ones that confer the protective 
immunity against Leishmaniasis. However, some studies indicate CD8+ Th cells as responsible 
for asymptomatic infection of dogs and resistance to Leishmania infection (Barbiéri, 2006).  
Leishmaniasis in cats seems to involve the cellular immune response, with activation of 
macrophages for the destruction of the intracellular forms amastigotes. The high antibodies 
titers, usually present in some dogs and also in some symptomatic cats, do not confer immunity 
against the disease (Barbiéri, 2006). Nevertheless, some investigations showed that animals 
with increased titers of anti-Leishmania antibodies presented decreased positivity for the 
presence of DNA in the PCR methodology whereas the biggest positivity of PCR occured more 
frequently in cats with reduced antibody titers (Martín-Sánchez et al., 2007; Costa et al., 2010). 
This corroborates the hypothesis that immune response in felids differs from the one observed 
in dogs, justifying the high number of asymptomatic infected of cats, and the variable clinical 
manifestation of the disease, showing that lesions occur before the production of antibodies. 
When these lesions are in a resolution phase, seroconversion occurs, what could suggest that 
humoral immune response is protective in FeL. On the other hand, it shows that conventional 
serological methods to detect active infection in cats are not always reliable (Martín-Sánchez et 
al., 2007). 
The natural resistance of cats to Leishmaniasis is widely suggested by the spontaneous healing 
of the lesion, which is often characterized by minimal or limited pathological changes (Simões-
Mattos et al., 2005; Navarro et al., 2010). The parasite dissemination and its interaction with the 
host’s immune system is reflected in organic changes such as lymph node hypertrophy due to 
the proliferation of blastic lymphoid cells in lymphoid follicles. If the immune response is not 
cellular, the proliferative reaction will involve macrophages, plasma cells, reticular cells 
migration, with decrease in the number of lymphocytes. Hyperplasia of the connective tissue 
occurs when the process becomes chronic, noticeable with fibrosis. Granulomas are rich in 
macrophages, granulocytes and T-cells, representing a good immune response. Dermatological 
ulcer can ensue, with cellular cytotoxic phenomena, or alternatively with deposition of immune 
complexes and organ hyperplasia (Santos et al., 2008). 
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7. Diagnosis 
Laboratory methods are important for the diagnosis of Leishmania infection, as a complement of 
the physical examination. Particularly in clinically manifested VL, hemogram and biochemical 
analysis frequently show leukocytose with neutrophilia, as well as urea and aspartate 
aminotransferase above of the values of reference. Creatinine, alanine aminotransferase and 
alkaline phosphatase can present normal values (da Silva et al., 2010). Neutrophilia, with 
monocytosis and hyperglobulinemia with polyclonal gammopathy was also reported (Leiva et 
al., 2005). 
Laboratory methods of diagnosis of infection are generally classified as direct or indirect. A 
direct method will detect the parasite or some of its parts or antigens. Examples include PCR, 
Restriction Fragment Length Polymorphism (RFLP), immunohistochemistry, observation of the 
parasite in culture, in smears and in histologic sections of organs infected by Leishmania. An 
indirect method will detect the immune response against the parasite, whether the humoral 
response e.g. IFI, Indirect-Enzyme-Linked Immunosorbent Assay (ELISA), Direct Agglutination 
Test (DAT) or the cellular response (e.g. Delayed Hypersensitivity Test – DHT). 
The direct observation of the parasite might be done through cytology and/or skin biopsy, 
namely from cutaneous lesions, lymph node or bone marrow (Ozon et al., 1998; Costa et al., 
2010).Cytology, by aspiration or impression, can be carried out during the necropsy (Bresciani 
et al., 2010), in affected organs with VL as liver, spleen and kidney (Grevot et al., 2005; Marcos 
et al., 2009). Recently, Costa et al. (2010) demonstrated that direct parasitological examination 
of popliteal lymph node by aspiratory cytology was more sensitive when compared with the 
cytology from other organs, such as the bone marrow, spleen or liver.  
Marcos et al. (2009) found Leishmania infantum amastigotes in the cytoplasm of neutrophils in 
both blood and buffy coat smears (4 % of the neutrophils). 
In Portugal, a case of VL was reported in a 4-years-old domestic short-hair neutered female cat 
confirmed as FIV- and FeLV-negative (Marcos et al., 2009). After necropsy, Leishmania 
infantum amastigotes forms were found in the buffy coat and bone marrow smears, as well as in 
the splenic parenchyma and the follicular centers of lymph nodes. 
Histopathology is referred as a method with an acceptable sensitivity and specificity for the 
diagnosis, especially in cats with cutaneous lesions. Pocholle et al. (2012) found Leishmania 
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amastigotes through histopathologic examination of cutaneous lesions in cats even when there 
was no suspicion of Leishmaniasis. Furthermore, immunohistochemistry techniques can be 
used for confirmation of histopathological examination (Navarro et al., 2010), or as first line 
diagnosis (Vides et al., 2011). 
The culture of Leishmania promastigotes is an additional direct method, but it has some 
disadvantages as it features a low sensitivity and is time consuming, taking too long to get the 
results (Pocholle et al., 2012). When employed, the samples used for culture are blood, bone 
marrow or lymph nodes. Nevertheless, some authors (Martín-Sánchez et al., 2007) consider 
that blood is a not suitably sensitive specimen for culture in cats, because of the low 
parasitaemia and small amount collected for this purpose, resulting in lower sensitivity of the 
culture method.   
The traditional methods such as cytology and culture are less sensitive than the new molecular 
methods and do not allow the identification of Leishmania species (Akhavan et al., 2010).The 
established higher sensitivity of molecular techniques such as PCR, makes it a good option to 
confirm the diagnosis and for the detection of asymptomatic animals (Gramiccia and Gradoni, 
2005). PCR is a DNA amplification technique of a specific fragment in a complex mixture by 
multiple cycles of DNA synthesis from oligonucleotide primers followed by short thermal 
treatments to separate the complementary strands. Nevertheless, the detection of DNA of 
Leishmania does not necessarily mean the existence of an active infection. Recently Morais et 
al. (2013) showed some advantages of Real time PCR (qPCR) as compared with conventional 
PCR (cPCR). In qPCR fluorescent report dyes are used to combine the steps of amplifications 
and DNA quantification in a single tube format, being the results given in real time. The 
advantages of qPCR include higher sensitivity and specificity, faster execution, and possibility of 
quantification of the DNA. Indeed, in the mentioned study of Morais et al. (2013) the samples 
with low parasitic load gave negative results in cPCR, but qPCR confirmed its positivity. The 
most suitable sample to detect the DNA of Leishmania is material obtained from puncture of 
lymph nodes (Maia et al. 2010).  
RFLP is a molecular technique that is used in association with PCR, to compare the different 
electrophoretic patterns of restriction fragments (amplicons after digestion with restriction 
enzymes). With this molecular technique the variations in homologous DNA sequences are 
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analyzed and recognized, which allows protozoan classification in zymodemes (Dahroug et al., 
2011; Ruiz-Fons et al., 2013). 
Regarding the indirect methods for FeL diagnosis, the most important ones are the serological 
techniques, i.e. assays that detect antibodies. Examples of serological assays already used in 
epidemiological surveys (Table 1) and diagnosis of reported clinical cases (Table 2) of FeL 
include IFI, Western Blot (WB), indirect-ELISA and DAT. When considering serological assays, 
it is important to bear in mind that the cat’s immune response against Leishmania differs from 
that observed in dogs, either by the number of infected animals, asymptomatic occurrence, or 
by the clinical signs of infected animals (Martín-Sánchez et al., 2007; Costa et al., 2010). In 
addition, and as depicted in Table 1 and further discussed in the previous section (vide section 
6) feline serological surveys show a low seroprevalence of FeL, probably as consequence of 
the predominant cellular immune response in cats which results in low antibody titers or even in 
seronegativity (Marcos et al., 2009; Maia et al., 2010.). Nevertheless, some authors (Maroli et 
al., 2007) refer that FeL has increased in the South of Europe and along with its corresponding 
seroprevalence rate, which although considered low in cats, has come closer to the rate 
reported in dogs in endemic areas. The use of cut-off antibody titers or even reagents produced 
specifically for dogs can further explain such low seroprevalence (Maroli et al., 2007; Longoni et 
al., 2012). As in all serological analysis, the time of sample collection is determinant. Maroli et 
al. (2007) described a cat infected with Leishmania infantum, which initially was seronegative, 
but presented seroconversion some time after the first serology. 
One of the most important serological techniques is the IFI, also known as Indirect 
Fluorescence Antibody test (IFAT). IFI consists in the detection of antibodies anti-Leishmania 
which bind the target promastigote forms immobilized in a microscope slide. The presence of 
antibodies anti-Leishmania allows the visualization of the forms given that the secondary 
antibodies are bound to fluorochromes. The results are observable in a fluorescence 
microscope. The use of the promastigote forms as antigens renders specificity to the method, 
because these are the infectious form to the cat, inducing macrophage phagocytosis by specific 
union to their membrane molecules (Tomás and Romão, 2008). IFI is considered as highly 
sensitive in case of HuL (83.3 %) and CaL (87.5 %) (Maia et al., 2008) However, IFI lacks 
sensitive in the diagnosis of Leishmania infection in cats, since the titers of antibodies anti-
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Leishmania remain low. Thus although the IFI is considered the reference technique of CaL 
diagnosis, its use in FeL diagnosis is not consensual (Longoni et al., 2012; Spada et al., 2013). 
The suggested IFI cut-off titer was 1:80 for cats (Solano-Gallego et al, 2013).  
Another serological technique is the ELISA, which uses the principle of antigen-antibody 
interaction to detect antibodies (if used as a serological technique) or proteins, such as those 
making up cellular components of the parasite (if used as a direct method of diagnosis). In the 
study of Nasereddin et al. (2008) the antibody titers assessed through ELISA ranged from1:2 to 
1:200. 
WB allows identification of specific target proteins. Proteins are first separated according to their 
molecular weight in an electrophoresis gel, and then identified by a specific directed antibody 
(Fonseca et al., 2008). Longoni et al. (2012) in their ELISA and WB serological investigation 
techniques utilized a molecular specific marker, highly immunogenic, named superoxide 
dismutase of iron (Fe-SOD). This marker signals antibodies, allowing the identification of 
Leishmania species, without reported cross-reaction between them. 
DAT is based in direct agglutination principle to detect specific anti-Leishmania antibodies. This 
technique uses Leishmania promastigotes, and react with serum antibodies. Serial two-fold 
dilutions are made (Cardoso et al., 2010). 
Additionally, positive DTH indirectly proves exposure to the parasite (Solano-Gallego et al., 
2000). 
Interestingly, in an original strategy, Maroli et al. (2007) diagnosed FeL by the so called 
phlebotomy. Briefly, in a laboratorial and controlled environment, the patient was submitted to 
Phlebotomus perniciosus females bite, negatives for the Leishmania. After a 90 minutes meal, 
the sand flies were dissected and promastigote forms of the parasite were found, proving, for 
the first time, the natural infection to a competent vector of L. infantum, through a chronically 
sick feline patient. The xenodiagnoses of Leishmania infantum in a feline from Brazil was 
equally proven by da Silva et al. (2010) involving phlebotomy with Lutzomyia longipalpis. 
 
8. Therapy and Prevention Strategies 
The information about therapeutic efficacy in FeL cases is rare, with little investigated cases 
given that the majority of the anti-Leishmanial drugs have been studied for dogs only. Even for 
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dogs, some of the studied and homologated treatment options are not considered as capable of 
complete cure (Solano-Gallego and Baneth, 2006). In addition, recently, Aït-Oudhia et al. (2012) 
claimed that the lineage of Leishmania is also related with the host’s clinical manifestation, as it 
can modulate the susceptibility or determine resistance to one drug. 
The naturally infected cats do not seem to recover without specific anti-Leishmanial therapy 
(Solano-Gallego et al., 2007). However, in a study conducted by Martín-Sánches et al. (2007), 
in Spain, a total of 27 cats, with FeL diagnosed by IFI and/or PCR, where monitored for 12 
months, during which, eleven of them evidenced good clinical status without any treatment for 
Leishmania. 
Drugs implemented in Leishmaniasis treatment are classified in two classes: leishmanistatics 
and leishmanicides. The first class includes allopurinol, a drug for gout / antimetabolite that 
inhibits the multiplication of parasites by inhibiting enzymes that are involved in the purine 
conversion, resulting a decreased capacity of synthesis of Adenosine Triphosphate (ATP) and 
Ribonucleic Acid (RNA) (Corrales, 2013).  
Leishmanicide includes drugs like meglumine antimoniate, or the new antiLeishmanial drug 
miltefosine, also studied for breast cancer. Antifungals (clotrimazole, ketonazole, and 
amphoterin B), pentamidine, paromomycin (an aminoglycoside also known as aminosidine) and 
levamisole may also be used in this approach, producing a decrease in Leishmania load. The 
concomitant use of a leishmanicide and allopurinol accomplishes a synergic action (Solano-
Gallego and Baneth, 2006; Corrales, 2013). 
Denuziére (1976) administrated 12 doses of pentamidine, IM, to a naturally infected cat, in the 
same dose recommended for the dogs. The cat reached clinical cure (Pennisi, 2002).  
Recently, Navarro et al. (2010) mentioned a positive clinical evolution of the 2 cats treated with 
allopurinol (one with 7- and 14-years-old, with blefatitis and conjuntivitis, respectively, and both 
with raised parasitic load). Allopurinol, 100mg/daily, was also administrated to a 14 years-old 
FIV-positive cat with history of recurrent pododermatitis for 3 years (case report described in the 
previous sections; Pocholle et al., 2012). After 4 months of treatment, this case of disseminated 
Leishmaniasis was considered in regression, with healing of the dermic lesions. The treatment 
contributed, furthermore to a reduction in the parasitaemia, presenting 11 parasites/mL in 
contrast with 26 parasites/mL at the beginning of the diagnosis. The cat died 3 months later in a 
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traffic accident and was submitted to necropsy. The post-mortem exam evidenced development 
of adiposity reservoirs, supporting the improvement of its clinical state. PCR confirmed the 
presence of parasites in the circulating blood.  
In Spain, the successfully therapy administered to a cat with dermatological injuries and visceral 
commitment consisted in a combination of meglumine antimoniate 5mg/kg/SID, SC with 
ketoconazole, 10mg/kg/SID, PO. Treatment was followed by 3 cycles of 4 weeks, with 10 days 
interval (Hervás et al., 1999; Solano-Gallego and Baneth, 2006). Already previously, the 
treatment with clotrimazole, followed of paromomycin 15%, topically implemented in a cat with 
L. mexicana infection, also with cutaneous lesions in the nose, was not effective. Six months 
later, the cat developed a new lesion in the nasal mucosa that was managed with levamisol 
(1mg/kg/48h), but without clinical success (Pennisi, 2002).  
Some cats with CL have shown regression or positive clinical evolution, by revealing low 
number of parasites in lymphocytes and macrophages. Already cats with ocular, visceral and 
mucocutaneous junction lesions presented, in the cytological exam, a low number of 
lymphocytes along with an increased number of parasites in the interior of the macrophages, 
indicating a cellular reply and healing process (Navarro et al., 2010). 
A cat with visceral commitment, receiving support therapy and allopurinol (10mg/kg, PO, q12h), 
was euthanized on day 20 as reported by Marcos et al. (2009). Support treatment is required, 
especially in patients that develop visceral compromise, such as hepatic failure and chronic 
kidney disease, given the hepato- and nephrotoxic potential of some of the drugs. It is thus 
advised the monitoring of hepatic and renal functions in cats subjected to anti-Leishmanial 
therapy (Solano-Gallego and Pennisi, 2013). 
Prevention is reiterated as the main goal, to make possible a timely diagnosis. Application of 
topical insecticides is a preventing mechanism of the sand flies bite. Repellents should also be 
used in animals that inhabit or travel, even if only temporarily, in endemic zones (Gradoni, 
2013). Pyrethrins and pyrethroids are two recognized active principles that exert efficient 
repellent activity against phlebotomines. In the specific case of CaL control, this is a widely 
accepted and effective veterinary prophylactic measure. However, cats are sensible to 
pyrethrins and pyrethroids, because of the decreased hydrolysis of the esters of pyrethroids, 
which results in the existence of toxic metabolites that escape the hepatic degradation process. 
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Along with reduced glucoronidation, excretion of the same toxic metabolites from the feline 
organism is compromised (Stanneck et al., 2012a). Flumethrin, a recently available pirethroid 
class molecule, features an excretion of its metabolites by fecal route, without commitment of 
the hepatic glucuronidation. It is thus assured the safe use of flumethrin in cats which is 
reported as effective against ticks, fleas and arthropods (Stanneck et al., 2012b). Another 
tolerated active principle by cats is imidaclopride that, according to a study carried through in 
Italy, when combined with flumethrin showed efficacy in the prevention of CaL, in an area 
considered hyperendemic (Otranto et al., 2013). Another prophylaxis measure recommended in 
the endemic areas of Leishmaniasis is the use of impregnated nets and the spraying of the 
shelters and spaces of the human beings and animals with insecticide solutions. The spraying 
with dichlorodiphenyltrichloroethane (DDT), long ago applied to prevent the plagues of 
arthropods in the agricultural regions and the dispersion of malaria and of Leishmaniasis, had 
been considered as efficient for this purpose, preferably when the vectors were on the shelters. 
However, given the threatening secondary effects of the DDT its use was forsaken. 
The vaccination against the CaL is also possible nowadays, as an additional tool against 
Leishmaniasis (Quinnel and Courtenay, 2009). The development of immune cellular response 
seems to be dependent on the vaccine adjuvant, as well as the antigen combination utilized in 
the vaccine (Corrales, 2013). 
Gradoni (2013) still evokes for the mandatory Leishmaniasis notification in the problematic 
regions, and also in the not endemic contiguous areas to the first ones. 
 
9. Final remarks 
The significance of the cat as a reservoir of Leishmania and not simply an alternative host 
seems to be gaining ground, mainly because: i) cats can present increased seropositivity 
between serology analysis; ii) cats can be infected during some months and thus are available 
for sand flies; iii) cats transmit the Leishmania agent in a competent form (Silva et al., 
2008).This possibility is supported by the recent report of autochthonous FeL cases (Petersen, 
2009; Bourdoiseau, 2011). 
The proximity of cats with human to the sand fly, and its susceptibility to the inoculated agent, 
allows infection, with a chronic evolution, and makes possible the survival of the animal until the 
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next feeding of the sand flies, thus contributing to the transmission of the agent (Maia et al., 
2008). 
When clinical signs of FeL are present, they are usually cutaneous, with unspecific 
dermatological changes, that frequently occur in other feline diseases and if not diagnosed can 
contribute to an underestimation of the actual occurrence of the disease in cats (Poli et al., 
2002; Cardoso et al., 2010). The low seroprevalence titers (Cardoso et al., 2010) along with the 
commonly asymptomatic infection in cats can further contribute to the underestimation of FeL 
occurrence. 
These reasons reinforce the need to raise awareness about FeL among veterinarians and to 
carry out further studies to broaden the knowledge on the significance of this disease in cats, 
and the actual epidemiological role of these animals in the transmission of this important 
zoonosis.  
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